摘要
目的:评估青岛市全民补充医疗保险制度对肺动脉高压的保障效果,为政策完善提供参考和建议。方法:从患者医药费用角度对比大病医疗救助和全民补充医疗保险制度对患者的经济负担缓解情况。结果:全民补充医疗保险制度实施后,人均特药自费费用降至3 911.22元,全年医药费用个人自负比从政策前的30.09%降到18.42%,患者经济负担得到缓解。结论:青岛市全民补充医疗保险制度提高了肺动脉高压用特药波生坦的可负担性,大大减轻了患者的经济负担。
Objective： To estimate the effect of the universal supplementary medical insurance on pulmonary arterial hypertension （PAH） in Qingdao, and provide suggestions for improvement. Methods： For the aspect of patients＇ financial burden, the effect of catastrophic disease medical assistance policy was compared with that of universal supplementary medical insurance policy. Results： After the implementation of universal supplementary medical insurance, the average out-of-pocket payments for special drug was Y3 911.22 yuan per person, the self-burden rate was 30.09% before the implementation of policy and reduced to 18.42% after, so the patients＇ financial burden was relieved. Conclusion： The universal supplementary medical insurance in Qingdao makes bosentan affordable, greatly reducing the financial burden to patients.
作者
王艳
方海丽
陈明艳
李浩
WANG Yan1, FANG Hai-li2, CHEN Ming-yan3, LI Hao4(1.Management Center of Chronic Disease, Qingdao No.6 the People＇s Hospital, Shandong Qingdao 266034, China; 2.Department of Infectious Disease, shandong Qingdao Eighth People＇s Hospital, Shandong Qingdao 266034, China; 3.International Medical Commercial College, China Pharmaceutical University, Nanjing 211100, China; 4. Department of Social Insurance Cooperation and Development, Qingdao Social Insurance Bureau, Shandong Qingdao 266034, China)
出处
《临床药物治疗杂志》
2018年第2期18-21,共4页
Clinical Medication Journal
